These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1576455)

  • 1. The dexamethasone suppression test as an adjunct in diagnosing depression.
    Lawson WB; Herrera JM; Costa J
    J Assoc Acad Minor Phys; 1992; 3(1):17-9. PubMed ID: 1576455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
    Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study on the dexamethasone suppression test in major depression and acute schizophrenia].
    Gu NF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):36-40. PubMed ID: 3987457
    [No Abstract]   [Full Text] [Related]  

  • 6. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dexamethasone suppression test in schizophrenia and endogenous depression].
    Strzelecka I; Matkowski K; Linka M; Kanarkowski R; Kretowicz W; Chmielewska Z; Rybakowski J
    Psychiatr Pol; 1988; 22(1):1-7. PubMed ID: 3406212
    [No Abstract]   [Full Text] [Related]  

  • 9. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Re-analysis of the diagnostic significance of the dexamethasone suppression test in depression].
    Shen QJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):279-83. PubMed ID: 3833512
    [No Abstract]   [Full Text] [Related]  

  • 11. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment.
    Brown WA; Johnston R; Mayfield D
    Am J Psychiatry; 1979 Apr; 136(4B):543-7. PubMed ID: 426140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in depression--a Singapore study.
    Peh LH; Tay LK
    Singapore Med J; 1990 Apr; 31(2):147-52. PubMed ID: 2371580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seasonal variations in dexamethasone suppression test in psychiatric patients].
    de la Gándara Martín JJ; de Dios Francos A; Hernández Herrero H; Redondo Martínez AL; López Gómez I
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(2):94-102. PubMed ID: 2735221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the dexamethasone suppression test in the evaluation of depression: a re-examination.
    Bielski RJ; Holmes GA; West CL; Shafer CL
    J Am Osteopath Assoc; 1987 Apr; 87(4):302-5. PubMed ID: 3583846
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone suppression test and schizophrenia.
    Tsoi WF; Candlish JK; Tan KH
    Singapore Med J; 1986 Apr; 27(2):140-2. PubMed ID: 3749936
    [No Abstract]   [Full Text] [Related]  

  • 19. The dexamethasone suppression test: some limitations in the general hospital setting.
    Baron DA; Shea S; White K
    J Am Osteopath Assoc; 1984 Mar; 83(7):505-8. PubMed ID: 6706716
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific laboratory test for the diagnosis of primary depression. A review results.
    Höschl C; Stárka L; Roth Z; Vokálková J; Jassová J
    Acta Univ Carol Med (Praha); 1985; 31(5-6):347-67. PubMed ID: 3843526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.